Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer

BACKGROUND: The luminal subtype of breast cancer is sensitive to anti-estrogen therapy and shows a better prognosis than that of human epidermal growth factor receptor2 (HER2)-enriched or triple-negative breast cancer. However, the luminal type of breast cancer is heterogeneous and can have aggressi...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Chansub, Park, Kyeongmee, Kim, Jiyoung, Sin, Youngjoo, Park, Inseok, Cho, Hyunjin, Yang, Keunho, Bae, Byung Noe, Kim, Ki Whan, Ahn, Sookyung, Gwak, Geumhee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020449/
https://www.ncbi.nlm.nih.gov/pubmed/27619909
http://dx.doi.org/10.1186/s12957-016-0999-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020449/
https://www.ncbi.nlm.nih.gov/pubmed/27619909
http://dx.doi.org/10.1186/s12957-016-0999-x

Ejemplares similares